Jennifer Cote

CIK: 0001960481

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HBIO

HARVARD BIOSCIENCE INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

HBIO
HARVARD BIOSCIENCE INC
Mar 19, 2025
Tax Payment(F)
Direct
5.7K shares at avg. $0.69$4K
HBIO
HARVARD BIOSCIENCE INC
Dec 29, 2024
Tax Payment(F)
Direct
4.7K shares at avg. $1.98$9K
HBIO
HARVARD BIOSCIENCE INC
Dec 29, 2024
Tax Payment(F)
Direct
3.8K shares at avg. $1.98$8K

		Type	Shares	Price		Ownership
Mar 19, 2025	HBIO HARVARD BIOSCIENCE INC	Tax Payment(F)	5,687	$0.69	$3,916	Direct
Dec 29, 2024	HBIO HARVARD BIOSCIENCE INC	Tax Payment(F)	4,731	$1.98	$9,367	Direct
Dec 29, 2024	HBIO HARVARD BIOSCIENCE INC	Tax Payment(F)	3,797	$1.98	$7,518	Direct

1-3 of 3 transactions

About Cote Jennifer

Cote Jennifer (SEC CIK 0001960481) files insider reports with the SEC as Chief Financial Officer of HARVARD BIOSCIENCE INC (HBIO).

Signal8 holds 2 ownership filings by Cote Jennifer, all Form 4s, filed between Dec 31, 2024 and Mar 21, 2025. Those filings report 3 transactions, from Dec 29, 2024 to Mar 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Cote Jennifer's filings is in HOLLISTON, MA.

Recent filings by Cote Jennifer

Mar 19, 2025: Tax withholding of HBIO shares (Form 4, code F).
Dec 29, 2024: Tax withholdings of HBIO shares (2 lines, Form 4, code F).

Other insiders filing for HARVARD BIOSCIENCE INC (HBIO)

Eade Katherine A., Director
Snider William, Director
DENELSKY STEPHEN J, Director
Gagnon Robert E., Director
Benson Seth Benjamin, Director
Frost Mark T, Chief Financial Officer

How to read Form 4 transaction codes